surmount-1 tirzepatide weight loss non-diabetic Gastrointestinal tolerability and reduction associated with in adults with obesity or overweight with and without type 2 diabetes in the SURMOUNT‐1 to ‐4 trials - Rubino - 2025 Tirzepatide cuts diabetes risk by

Considering GLP-1s For Benefits Beyond Weight GLP-1 medications are expanding how we think about metabolic health

Aplican condiciones

Combining Wegovy with regular physical activity, a diet rich in omega-3s, protein, and complex carbohydrates, and psychological support where needed, supports both your weight loss and anxiety management

Keep a symptom diary noting bowel frequency, consistency (using the NHS Bristol Stool Chart as reference), associated symptoms, and dietary intake

Theres always that moment before your first injection, youve got the semaglutide pen or vial in your hand, youve read the instructions, and youre still hesitating